http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006089393-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2d522686b497397d3e7fe48e0c82801 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-121 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 |
| filingDate | 2004-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23f98930cbd05c5ddb7c81b52e69b3d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17964d972a81a7e064df849148f06838 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ea37340078820f352b92bba4d30e5a7 |
| publicationDate | 2006-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2006089393-A |
| titleOfInvention | Two-component mixed medicine |
| abstract | PROBLEM TO BE SOLVED: To provide a two-component combination agent suitable for the treatment of gastric disorders, which can obtain a sufficient effect even if the dose is reduced and can reduce side effects. A two-component mixed drug comprising a drug having a histamine H 2 receptor antagonistic action such as famotidine and a drug having a gastric mucosal protective action such as teprenone. As a result, the imbalance between the attack factor and the defense factor is eliminated. As a result, not only can each individual dose be reduced compared to a single drug, but also a therapeutic effect equal to or greater can be obtained. Can also be reduced. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104173801-A |
| priorityDate | 2004-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.